NEW YORK (GenomeWeb News) – Mizuho Securities today downgraded Life Technologies and Thermo Fisher Scientific on concerns about an uncertain academic spending environment.

In a research note, Peter Lawson downgraded both firms to Neutral from Buy. He lowered his price target for Life Tech to $45 from $52 and trimmed the price target for Thermo Fisher to $55 from $65.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.